Patrick Walsh

Track

Insider profile

Currently holds positions in Avid Bioservices Inc and ANI Pharmaceuticals, Inc.

Performance

Overall performance
3.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
13 62% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 186%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Independent Director Avid Bioservices Inc Oct. 20, 2017 -
Interim President, Chief Executive Officer, Director ANI Pharmaceuticals, Inc. May 11, 2020 -
Independent Director ANI Pharmaceuticals, Inc. May 17, 2018 - May 11, 2020
Patrick Walsh's trades of ANI Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
427.44
Quantity 79,813
Value US$1,462,521
Transaction date
Sale
Price
48.06
Quantity 11,380 -39.1%
Value US$3,120,256
Transaction date
Sale
Price
80.75
Quantity 3,973 -7.6%
Value US$320,820
Transaction date
Proposed sale
Price
80.75
Quantity 3,973
Value US$320,820
Transaction date
Sale
Price
74.23
Quantity 6,000 -10.3%
Value US$445,380
Transaction date
Proposed sale
Price
74.23
Quantity 6,000
Value US$445,390
Transaction date
Proposed sale
Price
86.88
Quantity 8,643
Value US$750,914
Transaction date
Sale
Price
89.05
Quantity 9,000 -11.4%
Value US$801,450
Transaction date
Proposed sale
Price
89.05
Quantity 9,000
Value US$801,450
Transaction date
Purchase
Price
11.26
Quantity 10,000 +33.3%
Value US$112,600
Transaction date
Purchase
Price
25.96
Quantity 5,000 +16.6%
Value US$129,800
Transaction date
Purchase
Price
30.89
Quantity 3,000 +11.1%
Value US$92,670
Transaction date
Purchase
Price
30.98
Quantity 4,000 +17.3%
Value US$123,920
Transaction date
Purchase
Price
30.40
Quantity 3,000 +14.9%
Value US$91,200
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-07
PrS Proposed sale
79,813
427.44
US$1,462,521 		79,813 427.44 US$1,462,521
2026-05-13 2026-05-13
S Sale
11,380 -39.1%
48.06
US$3,120,256 		11,380 -39.1% 48.06 US$3,120,256
2026-05-13 2026-05-13
PrS Proposed sale
27,568
227.69
US$3,328,167 		27,568 227.69 US$3,328,167
2026-05-13 2026-05-11
S Sale
3,973 -7.6%
80.75
US$320,820 		3,973 -7.6% 80.75 US$320,820
2026-05-11 2026-05-11
PrS Proposed sale
3,973
80.75
US$320,820 		3,973 80.75 US$320,820
2026-03-03 2026-03-03
S Sale
6,000 -10.3%
74.23
US$445,380 		6,000 -10.3% 74.23 US$445,380
2026-03-03 2026-03-03
PrS Proposed sale
6,000
74.23
US$445,390 		6,000 74.23 US$445,390
2025-11-17 2025-11-13
S Sale
8,643 -12.3%
86.88
US$750,904 		8,643 -12.3% 86.88 US$750,904
2025-11-13 2025-11-13
PrS Proposed sale
8,643
86.88
US$750,914 		8,643 86.88 US$750,914
2025-08-18 2025-08-15
S Sale
9,000 -11.4%
89.05
US$801,450 		9,000 -11.4% 89.05 US$801,450
2025-08-15 2025-08-15
PrS Proposed sale
9,000
89.05
US$801,450 		9,000 89.05 US$801,450
2022-03-22 2022-03-21
B Purchase
5,000 +10.3%
27.76
US$138,794 		5,000 +10.3% 27.76 US$138,794
2021-04-22 2021-04-20
B Purchase
10,000 +33.3%
11.26
US$112,600 		10,000 +33.3% 11.26 US$112,600
2021-03-17 2021-03-15
B Purchase
4,000 +11.4%
32.89
US$131,555 		4,000 +11.4% 32.89 US$131,555
2020-11-12 2020-11-09
B Purchase
5,000 +16.6%
25.96
US$129,800 		5,000 +16.6% 25.96 US$129,800
2020-08-12 2020-08-10
B Purchase
3,000 +11.1%
30.89
US$92,670 		3,000 +11.1% 30.89 US$92,670
2020-08-12 2020-08-10
B Purchase
4,000 +17.3%
30.98
US$123,920 		4,000 +17.3% 30.98 US$123,920
2020-08-12 2020-08-10
B Purchase
3,000 +14.9%
30.40
US$91,200 		3,000 +14.9% 30.40 US$91,200
2020-03-25 2020-03-23
B Purchase
30,000 +inf%
3.22
US$96,600 		30,000 +inf% 3.22 US$96,600